AMENDMENT NO. 1 TO CREDIT AGREEMENTCredit Agreement • April 10th, 2015 • Sagent Pharmaceuticals, Inc. • Pharmaceutical preparations • Illinois
Contract Type FiledApril 10th, 2015 Company Industry JurisdictionThis AMENDMENT NO. 1 TO CREDIT AGREEMENT (this “Amendment”) is dated as of April 6, 2015, and is entered into by and among SAGENT PHARMACEUTICALS, a Wyoming corporation (“Borrower”), JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”) and the Lenders.
GUARANTYGuaranty • April 10th, 2015 • Sagent Pharmaceuticals, Inc. • Pharmaceutical preparations • Illinois
Contract Type FiledApril 10th, 2015 Company Industry JurisdictionThis GUARANTY, dated as of April 6, 2015 (this “Guaranty”), is made by each of Sagent Pharmaceuticals, Inc., a Delaware corporation (“Sagent”), and Sagent Pharmaceuticals, a Wyoming corporation (the “Company”; together with Sagent, collectively, the “Guarantors” and individually, each a “Guarantor”), for the benefit of JPMorgan Chase Bank, N.A. (“JPMC”), and each of the Lending Installations (as defined below) (together with the successors and assigns of JPMC and each Lending Installation, collectively, the “Creditors” and individually, each a “Creditor”). As used in this Guaranty, the term “JPMC Chinese Affiliate” means JPMorgan Chase Bank (China) Company Limited, together with its branches (including its Shanghai Branch), offices, facilities and affiliates.